
Debate
Author(s) -
Mark L. Fuerst
Publication year - 2019
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000616932.96451.a8
Subject(s) - nilotinib , medicine , bosutinib , side effect (computer science) , chronic myelogenous leukemia , family medicine , leukemia , imatinib , myeloid leukemia , computer science , programming language